Glimulin MF Forte Tablet PR is a combination oral hypoglycemic agent containing Glimepiride 1 mg and Metformin 1000 mg, formulated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, enhancing glucose uptake in muscle tissues. This combination provides complementary mechanisms to achieve better glycemic control in patients inadequately managed by diet and exercise alone. The prolonged-release formulation ensures a steady release of active ingredients, promoting improved patient compliance and minimizing gastrointestinal side effects commonly associated with Metformin. Glimulin MF Forte Tablet PR is indicated for adult patients with type 2 diabetes who require dual therapy to achieve target glycemic levels. It should be used alongside lifestyle modifications such as diet and exercise. Caution is advised in patients with renal or hepatic impairment, and regular monitoring of blood glucose and renal function is recommended. Common adverse effects may include hypoglycemia, gastrointestinal disturbances, and rare allergic reactions. This medication should be prescribed and monitored by healthcare professionals experienced in diabetes management.

Dosage & How to Use